Atlas Trials

The Effect of Albumin Value, HALP Score, and LCR Value on Predicting Survival and Recurrence in Patients With Pancreatic Adenocarcinoma

Clinical trial NCT06553040 · COMPLETED

Trial details

NCT number
NCT06553040
Sponsor
Ege University
Status
COMPLETED
Study type
OBSERVATIONAL
Pancreatic NeoplasmsPancreas Cancer
Start date
2017-01-01
Primary completion
2021-12-01
Enrollment
87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.